-
1
-
-
0023930868
-
Report of the National Cholesterol Education Program Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults
-
Report of the National Cholesterol Education Program Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults. Arch Intern Med 1988; 148:36-69.
-
(1988)
Arch Intern Med
, vol.148
, pp. 36-69
-
-
-
2
-
-
0000161902
-
Second report of the Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel II)
-
Second report of the Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel II). Circulation 1994;89:1330-1344.
-
(1994)
Circulation
, vol.89
, pp. 1330-1344
-
-
-
3
-
-
0015348189
-
Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
-
Friedwald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
-
(1972)
Clin Chem
, vol.18
, pp. 499-502
-
-
Friedwald, W.T.1
Levy, R.I.2
Fredrickson, D.S.3
-
4
-
-
0025900278
-
Effects of life-style modification on serum lipids
-
Barnard RJ. Effects of life-style modification on serum lipids. Arch Intern Med 1991;151:1389-1394.
-
(1991)
Arch Intern Med
, vol.151
, pp. 1389-1394
-
-
Barnard, R.J.1
-
5
-
-
0023153935
-
Effects of low-fat, low-cholesterol diet on serum lipids, platelet aggregation and thromboxane formation
-
Barnard RJ, Hall JA, Chaudhari A, Miller JE, Kirschenbaum MA. Effects of low-fat, low-cholesterol diet on serum lipids, platelet aggregation and thromboxane formation. Prostaglandins Leukot Med 1987;26:241-252.
-
(1987)
Prostaglandins Leukot Med
, vol.26
, pp. 241-252
-
-
Barnard, R.J.1
Hall, J.A.2
Chaudhari, A.3
Miller, J.E.4
Kirschenbaum, M.A.5
-
6
-
-
0003364420
-
Pritikin approach to cardiac rehabilitation
-
Goodgold J, ed. St. Louis, MO: CV Mosby
-
Barnard RJ, Pritikin R, Rosenthal MB, Inkeles S. Pritikin approach to cardiac rehabilitation. In: Goodgold J, ed. Rehabilitation Medicine. St. Louis, MO: CV Mosby, 1988:267-284.
-
(1988)
Rehabilitation Medicine
, pp. 267-284
-
-
Barnard, R.J.1
Pritikin, R.2
Rosenthal, M.B.3
Inkeles, S.4
-
7
-
-
0026046390
-
Expanded clinical evaluation of lovastatin (EXCEL) Study results: III. Efficacy in modifying lipoproteins and implications for managing patients with moderate hypercholesterolemia
-
Bradford RH, Shear CL, Chremos AN, Dujovne C, Downton M, Franklin FA, Gould LA, Hesney M, Higgins J, Hurley DP, Langendorfer A, Nash DT, Pool JL, Schnaper H. Expanded clinical evaluation of lovastatin (EXCEL) Study results: III. Efficacy in modifying lipoproteins and implications for managing patients with moderate hypercholesterolemia. Am JMed 1991;91(suppl 1B):1B-24S.
-
(1991)
Am JMed
, vol.91
, Issue.SUPPL. 1B
-
-
Bradford, R.H.1
Shear, C.L.2
Chremos, A.N.3
Dujovne, C.4
Downton, M.5
Franklin, F.A.6
Gould, L.A.7
Hesney, M.8
Higgins, J.9
Hurley, D.P.10
Langendorfer, A.11
Nash, D.T.12
Pool, J.L.13
Schnaper, H.14
-
8
-
-
0027153578
-
Lovastatin 5-year safety and efficacy study
-
Lovastatin Study Groups I through IV. Lovastatin 5-year safety and efficacy study. Arch Intern Med 1993;153:1079-1087.
-
(1993)
Arch Intern Med
, vol.153
, pp. 1079-1087
-
-
-
9
-
-
0027507820
-
Effects of pravastatin in patients with serum total cholesterol levels from 5.2 to 7.8 mmol/liter (200 to 300 mg/dl) plus two additional atherosclerotic risk factors
-
The Pravastatin Multinational Study Group for Cardiac Risk Patients. Effects of pravastatin in patients with serum total cholesterol levels from 5.2 to 7.8 mmol/liter (200 to 300 mg/dl) plus two additional atherosclerotic risk factors. Am J Cardiol 1993;72:1031-1037.
-
(1993)
Am J Cardiol
, vol.72
, pp. 1031-1037
-
-
-
10
-
-
0027400941
-
The efficacy of intensive dietary therapy alone or combined with lovastatin in outpatients with hypercholesterolemia
-
Hunninghake DB, Stein EA, Dujovne CA, Harris WS, Feldman EB, Miller VT, Tobert JA, Laskarzewski PM, Quiter E, Held J, Taylor AM, Hopper S, Leonard SB, Brewer BK. The efficacy of intensive dietary therapy alone or combined with lovastatin in outpatients with hypercholesterolemia. N Engl J Med 1993;328:1213-1219.
-
(1993)
N Engl J Med
, vol.328
, pp. 1213-1219
-
-
Hunninghake, D.B.1
Stein, E.A.2
Dujovne, C.A.3
Harris, W.S.4
Feldman, E.B.5
Miller, V.T.6
Tobert, J.A.7
Laskarzewski, P.M.8
Quiter, E.9
Held, J.10
Taylor, A.M.11
Hopper, S.12
Leonard, S.B.13
Brewer, B.K.14
-
12
-
-
0026762626
-
Is fat restriction needed with HMG-CoA reductase inhibitor treatment
-
Clifton PM, Wight MB, Nestle PJ. Is fat restriction needed with HMG-CoA reductase inhibitor treatment. Atherosclerosis 1992;93:59-70.
-
(1992)
Atherosclerosis
, vol.93
, pp. 59-70
-
-
Clifton, P.M.1
Wight, M.B.2
Nestle, P.J.3
-
13
-
-
0025963816
-
Lovastatin efficacy in reducing low-density lipoprotein cholesterol levels on high- vs low-fat diets
-
Cobb MM, Teitelbaum HS, Breslow JL. Lovastatin efficacy in reducing low-density lipoprotein cholesterol levels on high- vs low-fat diets. JAMA 1991;265:997-1001.
-
(1991)
JAMA
, vol.265
, pp. 997-1001
-
-
Cobb, M.M.1
Teitelbaum, H.S.2
Breslow, J.L.3
-
14
-
-
0027055293
-
Dietary management of patients with familial hypercholesterolemia treated with Simvastatin
-
Chisholm A, Mann J, Sutherland W, Williams S, Ball M. Dietary management of patients with familial hypercholesterolemia treated with Simvastatin. Q J Med 1992;307/308:825-831.
-
(1992)
Q J Med
, vol.307-308
, pp. 825-831
-
-
Chisholm, A.1
Mann, J.2
Sutherland, W.3
Williams, S.4
Ball, M.5
-
15
-
-
0027987849
-
Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
-
Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-1389.
-
(1994)
Lancet
, vol.344
, pp. 1383-1389
-
-
|